CytomX Therapeutics Inc (CTMX)
0.89
+0.02
(+2.71%)
USD |
NASDAQ |
Nov 22, 16:00
0.8913
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Shareholders Equity (Quarterly): -23.45M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -23.45M |
| June 30, 2024 | -31.23M |
| March 31, 2024 | -31.68M |
| December 31, 2023 | -47.45M |
| September 30, 2023 | -51.24M |
| June 30, 2023 | -85.03M |
| March 31, 2023 | -86.64M |
| December 31, 2022 | -85.75M |
| September 30, 2022 | 28.47M |
| June 30, 2022 | 48.71M |
| March 31, 2022 | 68.19M |
| December 31, 2021 | -0.459M |
| September 30, 2021 | 111.67M |
| June 30, 2021 | 130.95M |
| March 31, 2021 | 146.02M |
| December 31, 2020 | -7.774M |
| September 30, 2020 | 48.06M |
| June 30, 2020 | 58.83M |
| March 31, 2020 | 69.77M |
| December 31, 2019 | 51.11M |
| Date | Value |
|---|---|
| September 30, 2019 | 82.11M |
| June 30, 2019 | 101.50M |
| March 31, 2019 | 122.57M |
| December 31, 2018 | 130.88M |
| September 30, 2018 | 157.66M |
| June 30, 2018 | 41.13M |
| March 31, 2018 | 49.65M |
| December 31, 2017 | 69.90M |
| September 30, 2017 | 45.48M |
| June 30, 2017 | 52.24M |
| March 31, 2017 | 73.79M |
| December 31, 2016 | 78.48M |
| September 30, 2016 | 89.42M |
| June 30, 2016 | 101.19M |
| March 31, 2016 | 112.71M |
| December 31, 2015 | 126.07M |
| September 30, 2015 | -106.05M |
| June 30, 2015 | 63.60M |
| December 31, 2014 | -78.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-86.64M
Minimum
Mar 2023
146.02M
Maximum
Mar 2021
15.56M
Average
14.01M
Median
Shareholders Equity (Quarterly) Benchmarks
| Spero Therapeutics Inc | 65.51M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 138.98M |
| Total Liabilities (Quarterly) | 162.43M |
| Current Ratio | 1.042 |